Foresight Diagnostics Announces Three Presentations Highlighting Clinical Studies Using Patented PhasED-Seq® MRD Platform at the 64th American Society of Hematology Annual Meeting and Exposition
/PRNewswire/ -- Foresight Diagnostics, a leader in minimal residual disease (MRD) detection technology, announced today that three studies utilizing their...